Baudax Bio, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • R&D
    • Product Portfolio
    • ANJESO® (meloxicam) injection
    • NMB & Reversal Agent
    • Investigator Sponsored Research
  • Therapeutic Areas
    • Post-Operative Pain
    • Anesthesia
  • News & Investors
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Governance
    • Stock Info
    • Financial & Filings
  • Contact
  • Careers

Presentations

News & Investors

News & Investors

  • Overview
  • Press Releases
  • Events
  • Presentations
  • Governance
    • Governance Documents
    • Board of Directors
    • Board Committees
  • Stock Info
    • Form 8937
  • Financial & Filings
    • Overview
    • All SEC Filings
Corporate Overview

Corporate Overview

Mar 13, 2023
Seeing Future of Pharmaceutical Bio-Investment

Seeing Future of Pharmaceutical Bio-Investment

Jan 31, 2023
Corporate Overview

Corporate Overview

Jan 9, 2023
Baudax Bio H.C. Wainwright Global Life Sciences Conference Presentation

Baudax Bio H.C. Wainwright Global Life Sciences Conference Presentation

Jun 15, 2022
Baudax Bio Noblecon18 Presentation

Baudax Bio Noblecon18 Presentation

Apr 20, 2022
Safety and Efficacy of Preoperative Meloxicam IV in Colorectal Surgery

Safety and Efficacy of Preoperative Meloxicam IV in Colorectal Surgery

Jul 30, 2020
Healthcare Resource Utilization (HRU) Associated with Preoperative Meloxicam IV in Colorectal Surgery

Healthcare Resource Utilization (HRU) Associated with Preoperative Meloxicam IV in Colorectal Surgery

May 5, 2020
Efficacy and Safety of Preoperative Meloxicam IV in Primary Total Knee Arthroplasty

Efficacy and Safety of Preoperative Meloxicam IV in Primary Total Knee Arthroplasty

Apr 23, 2020
Healthcare Resource Utilization Associated with Preoperative Meloxicam IV in Primary Total Knee Arthroplasty

Healthcare Resource Utilization Associated with Preoperative Meloxicam IV in Primary Total Knee Arthroplasty

Apr 23, 2020
An Ex-vivo Assessment of the Effects of Meloxicam IV on Platelet Function

An Ex-vivo Assessment of the Effects of Meloxicam IV on Platelet Function

Dec 10, 2018
RSS
  • 1
  • 2
  • Next »
  • Email Alerts
  • Tear Sheet
  • RSS News Feed
© 2023 Baudax Bio, Inc. All Rights Reserved. ANJESO is a registered trademark of Baudax Bio, Inc.
Privacy Policy Terms of Use Disclaimer Sitemap